Surge In Imunon (IMNN) Stock Following Promising Phase 2 Results
Imunon, Inc.’s (NASDAQ: IMNN) stock price has increased dramatically after the release of topline data from a critical clinical study. According to the most recent report, IMNN’s shares have increased 149.58% to $2.96. Good Results in the Second Phase of the OVATION Study Positive topline data from the Phase 2 OVATION 2 research, which assessed […]